These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 29737246

  • 21. Lectin-like oxidized LDL receptor-1 expresses in mouse bone marrow-derived mesenchymal stem cells and stimulates their proliferation.
    Zhang F, Wang C, Jing S, Ren T, Li Y, Cao Y, Lin J.
    Exp Cell Res; 2013 Apr 15; 319(7):1054-9. PubMed ID: 23399833
    [Abstract] [Full Text] [Related]

  • 22. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway.
    Qian W, Cai X, Qian Q, Zhuang Q, Yang W, Zhang X, Zhao L.
    Drug Des Devel Ther; 2019 Apr 15; 13():2579-2589. PubMed ID: 31440038
    [Abstract] [Full Text] [Related]

  • 23. Protamine may have anti-atherogenic potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1.
    Takemura Y, Okamoto M, Hasegawa M, Hatanaka K, Kubota S.
    Biosci Biotechnol Biochem; 2019 Jun 15; 83(6):1094-1101. PubMed ID: 30871430
    [Abstract] [Full Text] [Related]

  • 24. Effects of flow on LOX-1 and oxidized low-density lipoprotein interactions in brain endothelial cell cultures.
    Mao X, Xie L, Greenberg DA.
    Free Radic Biol Med; 2015 Dec 15; 89():638-41. PubMed ID: 26462413
    [Abstract] [Full Text] [Related]

  • 25. Myeloperoxidase-Oxidized LDL Activates Human Aortic Endothelial Cells through the LOX-1 Scavenger Receptor.
    El-Hajjar L, Hindieh J, Andraos R, El-Sabban M, Daher J.
    Int J Mol Sci; 2022 Mar 04; 23(5):. PubMed ID: 35269979
    [Abstract] [Full Text] [Related]

  • 26. Degradation of heparan sulfate proteoglycans enhances oxidized-LDL-mediated autophagy and apoptosis in human endothelial cells.
    Ding Z, Wang X, Khaidakov M, Liu S, Dai Y, Mehta JL.
    Biochem Biophys Res Commun; 2012 Sep 14; 426(1):106-11. PubMed ID: 22910414
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway.
    Hong D, Bai YP, Gao HC, Wang X, Li LF, Zhang GG, Hu CP.
    Atherosclerosis; 2014 Aug 14; 235(2):310-7. PubMed ID: 24911634
    [Abstract] [Full Text] [Related]

  • 29. LOX-1 and obesity.
    Yan M, Mehta JL, Hu C.
    Cardiovasc Drugs Ther; 2011 Oct 14; 25(5):469-76. PubMed ID: 21881850
    [Abstract] [Full Text] [Related]

  • 30. Modulation of oxidized-LDL receptor-1 (LOX1) contributes to the antiatherosclerosis effect of oleanolic acid.
    Jiang Q, Wang D, Han Y, Han Z, Zhong W, Wang C.
    Int J Biochem Cell Biol; 2015 Dec 14; 69():142-52. PubMed ID: 26510581
    [Abstract] [Full Text] [Related]

  • 31. Depletion of CPEB1 protects against oxidized LDL-induced endothelial apoptosis and inflammation though SIRT1/LOX-1 signalling pathway.
    Xu K, Xiwen Liu, Ren G, Yin D, Guo S, Zhao Y.
    Life Sci; 2019 Dec 15; 239():116874. PubMed ID: 31521690
    [Abstract] [Full Text] [Related]

  • 32. Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis.
    Guo X, Guo Y, Wang Z, Cao B, Zheng C, Zeng Z, Wei Y.
    Oxid Med Cell Longev; 2022 Dec 15; 2022():7541411. PubMed ID: 35391927
    [Abstract] [Full Text] [Related]

  • 33. Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis.
    Tomar A, Sahoo S, Aathi M, Kuila S, Khan MA, Ravi GRR, Jeyaraman J, Mehta JL, Varughese KI, Arockiasamy A.
    Biochem Biophys Res Commun; 2022 Oct 01; 623():59-65. PubMed ID: 35872543
    [Abstract] [Full Text] [Related]

  • 34. Pinitol Protects Against Ox-Low-Density Lipoprotein-Induced Endothelial Inflammation and Monocytes Attachment.
    Chen XH, Tan Y, Yu S, Lu L, Deng Y.
    J Cardiovasc Pharmacol; 2022 Mar 01; 79(3):368-374. PubMed ID: 34861664
    [Abstract] [Full Text] [Related]

  • 35. Liraglutide ameliorates oxidized LDL-induced endothelial dysfunction by GLP-1R-dependent downregulation of LOX-1-mediated oxidative stress and inflammation.
    Ying W, Meiyan S, Wen C, Kaizu X, Meifang W, Liming L.
    Redox Rep; 2023 Dec 01; 28(1):2218684. PubMed ID: 37278349
    [Abstract] [Full Text] [Related]

  • 36. LOX-1: a male hormone-regulated scavenger receptor for atherosclerosis.
    Gao S, Geng YJ.
    Vascul Pharmacol; 2013 Dec 01; 59(5-6):138-43. PubMed ID: 24157503
    [Abstract] [Full Text] [Related]

  • 37. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.
    Singh S, Gautam AS.
    Curr Atheroscler Rep; 2019 Jul 27; 21(10):38. PubMed ID: 31350594
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: An insight into PI3K/Akt activation and STAT3 signaling pathways.
    Qin M, Luo Y, Meng XB, Wang M, Wang HW, Song SY, Ye JX, Pan RL, Yao F, Wu P, Sun GB, Sun XB.
    Vascul Pharmacol; 2015 Jul 27; 70():23-34. PubMed ID: 25849952
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.